Approval · Notice of Compliance 16625 · 2015
BAYTRIL: Notice of Compliance 16625
Issued February 20, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16625
- Date
- February 20, 2015
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update
- Therapeutic class
- Antimicrobial
Products in this notice
Medicinal ingredients
- ENROFLOXACIN 15 MG per TAB
- ENROFLOXACIN 50 MG per TAB
- ENROFLOXACIN 150 MG per TAB